Impact of the JUPITER trial on statin prescribing for primary prevention
Teng JF, Gomes T, Camacho X, Grundy S, Juurlink DN, Mamdani MM. Pharmacotherapy. 2014; 34(1):9-18. Epub 2013 Aug 12.
Publications
Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
Fleet JL, Shariff SZ, Bailey DG, Gandhi S, Juurlink DN, Nash DM, Mamdani M, Gomes T, Patel AM, Garg AX. BMJ Open. 2013; 3:e002857. Epub 2013 Jul 13.
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study
Antoniou T, Camacho X, Yao Z, Gomes T, Juurlink DN, Mamdani MM. CMAJ. 2013; 185(12):1035-41. Epub 2013 Jul 8.
Statin toxicity from macrolide antibiotic coprescription: a population-based study of older adults
Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, Gomes T, Fleet J, Hwang YJ, Garg AX. Ann Intern Med. 2013; 158(12):869-76.
Risk of incident diabetes among patients treated with statins: population based study
Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM. BMJ. 2013; 346:f2610. Epub 2013 May 23.
Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone
Lam J, Gomes T, Juurlink DN, Mamdani MM, Pullenayegum EM, Kearon C, Spencer FA, Paterson M, Zheng H, Holbrook AM. Am J Cardiol. 2013; 112(3):420-3. Epub 2013 May 8.
Effect of a course-based intervention and effect of medical regulation on physicians’ opioid prescribing
Kahan M, Gomes T, Juurlink DN, Manno M, Wilson L, Mailis-Gagnon A, Srivastava A, Reardon R, Dhalla IA, Mamdani MM. Can Fam Physician. 2013; 59(5):e231-9.
The risk of falls on initiation of antihypertensive drugs in the elderly
Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. Osteoporos Int. 2013; 24(10):2649-57. Epub 2013 Apr 24.
Trends in selection and timing of first-line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006
Foster PD, Mamdani MM, Juurlink DN, Shah BR, Paterson JM, Gomes T. Diabet Med. 2013; 30(10):1209-13. Epub 2013 Apr 16.
No increase in adverse events during aliskiren use among Ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers
Gilbert CJ, Gomes T, Mamdani MM, Hellings C, Yao Z, Garg AX, Wald R, Harel Z, Juurlink DN. Can J Cardiol. 2013; 29(5):586-91. Epub 2013 Apr 1.